Sangamo Therapeutics
SGMO
#8422
Rank
โ‚ฌ0.13 B
Marketcap
0,61ย โ‚ฌ
Share price
2.96%
Change (1 day)
27.99%
Change (1 year)

EPS for Sangamo Therapeutics (SGMO)

EPS in 2023 (TTM): -1,34ย โ‚ฌ

According to Sangamo Therapeutics 's latest financial reports the company's current EPS (TTM) is -1,25ย โ‚ฌ. In 2022 the company made an earnings per share (EPS) of -1,08ย โ‚ฌ a decrease over its 2021 EPS that were of -1,08ย โ‚ฌ.

EPS history for Sangamo Therapeutics from 2000 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-1,34ย โ‚ฌ23.94%
2022-1,08ย โ‚ฌ0.81%
2021-1,08ย โ‚ฌ33.33%
2020-0,81ย โ‚ฌ6.9%
2019-0,75ย โ‚ฌ22.54%
2018-0,62ย โ‚ฌ1.43%
2017-0,61ย โ‚ฌ-31.37%
2016-0,88ย โ‚ฌ75.86%
2015-0,50ย โ‚ฌ48.72%
2014-0,34ย โ‚ฌ-17.02%
2013-0,41ย โ‚ฌ9.3%
2012-0,37ย โ‚ฌ-39.44%
2011-0,62ย โ‚ฌ29.09%
2010-0,48ย โ‚ฌ22.22%
2009-0,39ย โ‚ฌ-25%
2008-0,52ย โ‚ฌ3.45%
2007-0,50ย โ‚ฌ5.45%
2006-0,48ย โ‚ฌ10%
2005-0,43ย โ‚ฌ-9.09%
2004-0,48ย โ‚ฌ30.95%
2003-0,36ย โ‚ฌ-65.29%
2002-1,05ย โ‚ฌ15.24%
2001-0,91ย โ‚ฌ3.96%
2000-0,88ย โ‚ฌ

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
3,81ย โ‚ฌ-404.86%๐Ÿ‡บ๐Ÿ‡ธ USA
-3,56ย โ‚ฌ 185.42%๐Ÿ‡บ๐Ÿ‡ธ USA
12,27ย โ‚ฌ-1,082.64%๐Ÿ‡บ๐Ÿ‡ธ USA
16,01ย โ‚ฌ-1,381.94%๐Ÿ‡บ๐Ÿ‡ธ USA
1,60ย โ‚ฌ-227.78%๐Ÿ‡บ๐Ÿ‡ธ USA
12,22ย โ‚ฌ-1,078.15%๐Ÿ‡บ๐Ÿ‡ธ USA
0,68ย โ‚ฌ-154.07%๐Ÿ‡บ๐Ÿ‡ธ USA
1,58ย โ‚ฌ-226.51%๐Ÿ‡บ๐Ÿ‡ธ USA